Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Genetics

Background:

• Elevated homocysteine (Hc) is linked to coronary artery disease and metabolic syndrome components like hypertension.
• The relationship between homocysteine and type II diabetes mellitus (T2DM) shows inconsistent findings in previous studies.
• Investigating the Hc-T2DM association in diverse populations is crucial for understanding metabolic health.

Purpose of the Study:

• To investigate the association between homocysteine levels and the risk of type II diabetes mellitus (T2DM).
• To examine the role of the MTHFR 667C>T gene variant in T2DM.
• To explore the impact of Hc and MTHFR 667C>T on T2DM correlates, including diuretic use.

Main Methods:

• A case-control study involving 2755 participants undergoing cardiac catheterization.
• Analysis of homocysteine (Hc) levels in relation to T2DM status.
• Assessment of the MTHFR 667C>T gene variant and its association with Hc and T2DM.

Main Results:

• Homocysteine levels were significantly lower in subjects with T2DM compared to those without (OR 0.640; p=0.0200), after adjusting for confounders.
• Hypertension showed a positive association with both high Hc levels and T2DM, contradicting the primary finding.
• The MTHFR 667C>T gene variant was significantly associated only with high Hc levels.

Conclusions:

• The study indicates population-specific variations in mechanisms modulating the Hc-T2DM association.
• Findings suggest that the relationship between homocysteine and type II diabetes mellitus is complex and context-dependent.
• Further research is warranted to elucidate these population-specific pathways.